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Jeff Stock is Professor of
Molecular Biology and Chemistry
at Princeton University where he
has taught biochemistry for over 20
years. He is best known for his
many contributions toward
understanding the molecular
mechanisms that underlie the
physiology and behavior of
bacteria.
What turned you on to biology
in the first place? I’ve always
been interested in biology. I grew
up in the Sonora Desert outside
Tucson, Arizona. I was a budding
pre-teen naturalist catching
snakes, lizards and tarantulas to
sell to collectors. I hunted
everything from horned toads to
birds and jackrabbits, and I had
every imaginable pet, including a
very large frog (grandpa), a
squirrel (chipper), a parrot
(Seattle), a monkey (Noname) and
a dog companion (Roger). In high
school I got hooked on
biochemistry. The biology teacher
had one of those impossibly
complex metabolic charts on the
wall. I thought the secret of life
had to be in there someplace.
Do you have a favorite paper?
Two: Monod, Wyman, Changeux
in 1965 on allostery (J. Mol. Biol.
12, 88–118); I especially like the
Bacon epigram, which speaks to
the heart of the two-state model;
and Spudich and Koshland in
1976 (Nature 262, 467–471) on
nongenetic individuality – it
provides convincing evidence that
bacteria have free will.
What is the best advice you’ve
been given? My undergraduate
advisor at Johns Hopkins, Spike
Carlson, told me that if I wanted to
be a biologist, I should study math,
physics and chemistry.
If you knew what you know now
earlier, would you pursue the
same career path? If ifs and
ands were pots and pans there’d
be no need for tinkers. In life there
are no controls. You cannot know
what would have happened had
you done something differently.
Up to now I’ve been very
fortunate, so in retrospect I have
no regrets.
What has been your biggest
mistake in research? I’ve had
lots of mistaken ideas, but like
many others, I like to think of these
periods of misapprehension as
enlightening experiences on the
path to discovery.
What is your favorite
conference? My favorite is the
one on bacterial locomotion and
signal transduction, which is held
every other year in Cuernavaca,
Mexico. I’ve never actually
attended, but my students have
always had a great time. My least
favorite conferences are the
monthly faculty meetings in our
department. I find myself unable to
refrain from making impolitic
statements that I later regret.
Do you have a scientific hero?
Benjamin Franklin for his wisdom
and wit – I keep an anthology of
“Poor Richard’s Almanac” by my
bed. There is no better source of
aphorisms for any occasion, for
example “God cures, the doctor
takes the fee” and “There’s
nothing so humble as an ambition
about to rise”.
What do you think about the
electronic revolution in
publishing? The ready availability
of information has been a heady
experience. When I was a student,
doing research was like trying to
solve a puzzle with most of the
pieces missing. The resulting
pictures were always a bit
nebulous. Now, most of the pieces
are there — the problem is picking
the ones that fit. It’s a lot more
fun, and the result can be quite
beautiful — like a new protein
structure or an evolutionary tree of
sequence relationships.
Do you have any strong views
on journals and the peer review
system? Like most, my
publication preferences are largely
determined by impact factor.
Whenever I have a paper rejected,
I feel angry and hurt — but the
result has always been a better
paper. The only strong view I have
in this realm is that one should not
judge a paper by the journal in
which it appears. A great paper is
great no matter where it’s
published, and a bad paper is
made worse by publication in a
high profile magazine.
What is your greatest ambition?
Right now, I would like to find a
drug to treat Alzheimer’s Disease.
Alzheimer’s – that seems a
stretch from your bacterial
work. Are you serious? Yes, very
much so. It turns out that the
chemistry responsible for memory
in bacteria may also play an
important role in human memory.
I’ve recently founded a company to
use this finding to develop drugs
for diseases like Alzheimer’s. It’s
called Signum Biosciences — we
just got our first round of financing.
What do you think are the big
questions to be answered next
in your field? During the latter half
of the 20th century, the chemical
foundations of nutrition and
genetics were formulated —
providing a solid scientific
foundation for understanding age-
old questions of nurture and
nature. The 21st century will see
similar advances in understanding
the molecular biology of
intelligence. The practical and
philosophical implications will be
profound.
Do you think students have
changed much since you were
an undergraduate? If so how? I
was a student during the height of
the cold war when a nuclear
holocaust seemed inevitable. This
tended to give us a rather
existentialist perspective. Students
today expect to see their 80th
birthdays so they tend to be
careerists. I’m reminded of a line
by Scott Fitzgerald at the end of
This Side of Paradise: “a new
generation dedicated more than
the last to the fear of poverty and
the worship of success; grown up
to find all Gods dead, all wars
fought, all faiths in man shaken.”
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